hypogonadism; oral-t/kyzatrex; patent

  1. madman

    Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (TU) CIII Capsules Extending Coverage to 2040

    Marius got this s**t on lock! * This newly allowed patent provides additional protection for KYZATREX through 2040 and further underscores the unique formulation and delivery attributes that differentiate it from other testosterone replacement therapies. * With six patents now protecting our...
Back
Top